Overview
Liver cancer is a malignancy arising in the tissues of the liver, encompassing primary tumors and metastatic disease, with hepatocellular carcinoma the most common primary form and cholangiocarcinoma of the intrahepatic bile ducts and rarer entities such as angiosarcoma also recognized. Hepatocellular carcinoma typically develops on a background of chronic liver injury and cirrhosis caused by viral hepatitis, alcohol, and metabolic disease, with hepatitis C infection an important driver; angiogenesis and the tumor microenvironment contribute to its progression. Diagnosis and prognosis rely on imaging, histopathology, and biomarkers, and management is shaped by tumor stage, underlying liver function, and comorbidity. Research addresses the epidemiology and burden of liver disease and cancer, angiogenic and molecular markers, organ-specific biomarker assessment, and the broader context of cancer comorbidity. The peer-reviewed studies indexed under this topic examine the prognosis of hepatic cancer, retrospective hospital-based study of liver disease, molecular and cellular biology relevant to tumor regulation, the role of angiogenic markers such as Tie2 and angiopoietin in hepatocellular carcinoma complicating hepatitis C infection, cell-based vital-organ biomarker assessment, and factors associated with mortality in cancer with comorbid disease. Together they reflect investigation of liver cancer spanning its epidemiology, molecular and angiogenic biology, biomarkers, and clinical context, integrating pathological, laboratory, and clinical perspectives on hepatic malignancy.
Research published in this journal
12 peer-reviewed articles, ranked by relevance. Each links to its DOI.
Liver Disease: A Retrospective Hospital Based Study in Addis Ababa-Ethiopia
Cell-Based Vital Organs Specific Biomarkers Assessment using Biofield Energy Based Novel Test Formulation
Impact of Biofield Energy Treatment Based Test Formulation on Vital Organ Health Specific Biomarkers Using Cell Line Study
In Vitro Cell-Based Biomarkers Study of Vital Organs: Impact of the Biofield Energy Based Test Formulation
RBM45: Molecular, Cellular, and Evolutionary Biology
Role of Tie2, CD14, Angiopoietin as Angiogenetic Markers in Hepatocellular Carcinoma Complicating Hepatitis C Virus Infection
Stratified Analysis of Factors Associated With Mortality in Patients With COVID-19 Based on Cancer and Diabetes
Epigenetics and Nutrition
Review on Public Health Effects of Aflatoxins in Milk and Milk-Based Foodstuffs of Dairy Cow
Complementary and Alternative Treatments for Cancer Prevention and Cure (Part 1)
Analysis of Clinical Prognostic Variables for Triple Negative Breast Cancer Histological Grading and Lymph Node Metastasis
How this research is being cited
The 12 articles above have been cited 29 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.
-
2026 · BioMed Research International
-
2026 · Italian Journal of Food Safety
-
2024 · Risk Management and Healthcare Policy
-
2024 · Heliyon
-
2024 · Таврійський науковий вісник Серія Технічні науки
-
2024 · Heliyon
-
Betelhem Zewdu Wubineh et al. · 2024 · EAI International Conference on ICT for Development for Africa
-
2024 · Risk Management and Healthcare Policy
A sample of recent works citing this journal's research on Liver Cancer, linking to each citing work.